Ornella Franzese

Rome, 00133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Antibacterial and Immunomodulatory Effects of Limosilactobacillus reuteri LMG P-27481 and Resveratrol Relevant for the Control of Upper Respiratory Tract Pathobionts.

Antibacterial and Immunomodulatory Effects of Limosilactobacillus reuteri LMG P-27481 and Resveratrol Relevant for the Control of Upper Respiratory Tract Pathobionts.

Journal: Microorganisms

Published: May 27, 2026

Determinants of Colorectal Cancer: An Integrative Immunometabolic Framework Linking Biomarkers, Therapy, and the Diet-Microbiota Axis.

Determinants of Colorectal Cancer: An Integrative Immunometabolic Framework Linking Biomarkers, Therapy, and the Diet-Microbiota Axis.

Journal: Cells

Published: April 14, 2026

VEGFR-1 blockade with the monoclonal antibody D16F7 counteracts VEGF-A-induced tolerogenic and immune regulatory phenotypes without impairing T-cell activation.

VEGFR-1 blockade with the monoclonal antibody D16F7 counteracts VEGF-A-induced tolerogenic and immune regulatory phenotypes without impairing T-cell activation.

Journal: International immunopharmacology

Published: December 05, 2025

Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches.

Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches.

Journal: Cancers

Published: March 31, 2025

Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes.

Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes.

Journal: International journal of molecular sciences

Published: November 02, 2024

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB.

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB.

Journal: Oncoimmunology

Published: June 25, 2024

Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy.

Apoptosis, a Metabolic "Head-to-Head" between Tumor and T Cells: Implications for Immunotherapy.

Journal: Cells

Published: April 12, 2024

CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response.

CD28/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 27, 2023

Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response.

Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response.

Journal: Biology

Published: June 30, 2023

T-cell repertoire diversity: friend or foe for protective antitumor response?

T-cell repertoire diversity: friend or foe for protective antitumor response?

Journal: Journal of experimental & clinical cancer research : CR

Published: October 26, 2022

Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints.

Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints.

Journal: Cancers

Published: August 03, 2022

Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?

Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?

Journal: International journal of molecular sciences

Published: August 05, 2021

Showing 1-12 of 36

Last Updated: 09/26/2026